Transepithelial prostacyclin gradient in isolated canine trachea.
Cyclooxygenase products of arachidonic acid, potential modulators of airway smooth muscle, have recently been described in bronchoalveolar lavage from canine lungs. To evaluate the possibility that airway epithelium represents a barrier to movement of prostacyclin (PGI2), an important bronchodilator synthesized by isolated airway, we measured the concentrations of 6-oxoprostaglandin F1 alpha (6-oxo-PGF1 alpha), the stable degradation product of PGI2, on the mucosal and serosal sides of isolated canine tracheal segments (CTS) mounted in Ussing chambers. 6-oxo-PGF1 alpha was measured by radioimmunoassay after purification by high-performance liquid chromatography. The concentration of 6-oxo-PGF1 alpha was significantly higher on the serosal than the mucosal side of CTS (1,262 +/- 252 vs. 390 +/- 168 pg.min-1.g-1, n = 8, P less than 0.05). A significant correlation was present between 6-oxo-PGF1 alpha measured on both sides of each CTS (r = 0.778, n = 26, P less than 0.01). 6-oxo-PGF1 alpha production from CTS stripped of mucosa was significantly greater than from isolated mucosa. Radiochromatograms obtained after incubation with [3H]arachidonic acid and calcium ionophore A23187 confirmed PGI2 as the predominant cyclooxygenase product of the submucosa, whereas the mucosa produced only small amounts of PGI2 in proportion to other cyclooxygenase products. PGI2 (10(-8) to 10(-6) M) applied to the mucosal surface of closed tracheal segments precontracted with histamine resulted in no significant relaxation, whereas serosal application showed a concentration-dependent effect. Radiolabeled 6-oxo-PGF1 alpha did not cross the isolated epithelium.(ABSTRACT TRUNCATED AT 250 WORDS)
Eidelman
D H
DH
Meakins-Christie Laboratories, McGill University, Montreal, Quebec, Canada.
Powell
W S
WS
Bellofiore
S
S
Martin
J G
JG
D015121:6-Ketoprostaglandin F1 alpha / Q000032:analysis / Q000096:biosynthesis / Q000493:pharmacokinetics; D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism*; D004285:Dogs; D004848:Epithelium / Q000502:physiology; D011464:Epoprostenol / Q000032:analysis / Q000493:pharmacokinetics*; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D009130:Muscle, Smooth / Q000032:analysis* / Q000378:metabolism; D014132:Trachea / Q000032:analysis* / Q000378:metabolism / Q000502:physiology
D001095:Arachidonic Acids; D015121:6-Ketoprostaglandin F1 alpha; D011464:Epoprostenol